Differential Association of Abdominal, Liver, and Epicardial Adiposity with Anthropometry, Diabetes, and Cardiac Remodeling in Asians

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Sep 11

PMID 39257902

Authors

Vivian Lee

Yiying Han

Desiree-Faye Toh

Jennifer A Bryant

Redha Boubertakh

Thu-Thao Le

Calvin W L Chin

Affiliations

Soon will be listed here.

Abstract

Background: Heterogenous deposition and homeostasis roles of physiologic and ectopic adipose tissues underscore the impact of fat compartmentalization on cardiometabolic risk. We aimed to characterize the distribution of abdominal visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), epicardial adipose tissue (EAT), and liver fat on magnetic resonance imaging (MRI), and evaluate their associations with anthropometric indices and adverse cardiac remodeling.

Methods: In this cross-sectional observational study, 149 Asian adults (57.0 ± 12.8 years; 65% males) with at least one cardiometabolic risk factor underwent multiparametric fat and cardiovascular MRI. Anthropometric indices included body mass index (BMI), waist circumference (WC), waist-hip ratio (WHR), and bioimpedance body fat mass (BFM). Associations between fat depots and anthropometric measures as well as cardiac remodeling features were examined as a single cohort and stratified by type 2 diabetes mellitus (T2DM) status.

Results: VAT and SAT had opposing associations with liver fat and EAT. Therefore the VAT/SAT ratio was explored as an integrated marker of visceral adiposity. VAT/SAT was positively associated with EAT (β=0.35, P<0.001) and liver fat (β=0.32, P=0.003) independent of confounders. Of the anthropometric measurements assessed, only WHR was independently associated with VAT/SAT (β=0.17, P=0.021). Individuals with T2DM had higher VAT and lower SAT compared to those without T2DM, translating to a significantly higher VAT/SAT ratio. EAT volume was independently associated with adverse features of cardiac remodeling: increased left ventricular (LV) mass (β=0.24, P=0.005), larger myocyte volume (β=0.26, P=0.001), increased myocardial fibrosis (β=0.19, P=0.023), higher concentricity (β=0.18, P=0.035), and elevated wall stress (β=-0.18, P=0.023).

Conclusion: Multiparametric MRI revealed abdominal VAT and SAT have differential associations with anthropometric indices and ectopic fats in a single cohort of Asians at risk of cardiometabolic disease. People with T2DM have expanded VAT and diminished SAT, endorsing the VAT/SAT ratio beyond usual anthropometric measurements as a marker for multiorgan visceral fat composition. Among the fat depots examined, EAT is uniquely associated with adverse cardiac remodeling, suggesting its distinctive cardiometabolic properties and implications.

References

Tosaki T, Kamiya H, Himeno T, Kato Y, Kondo M, Toyota K . Sodium-glucose Co-transporter 2 Inhibitors Reduce the Abdominal Visceral Fat Area and May Influence the Renal Function in Patients with Type 2 Diabetes. Intern Med. 2017; 56(6):597-604. PMC: 5410466. DOI: 10.2169/internalmedicine.56.7196. View

Oliveros E, Somers V, Sochor O, Goel K, Lopez-Jimenez F . The concept of normal weight obesity. Prog Cardiovasc Dis. 2014; 56(4):426-33. DOI: 10.1016/j.pcad.2013.10.003. View

Hayashi T, Boyko E, McNeely M, Leonetti D, Kahn S, Fujimoto W . Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes. 2008; 57(5):1269-75. DOI: 10.2337/db07-1378. View

Eslam M, Newsome P, Sarin S, Anstee Q, Targher G, Romero-Gomez M . A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020; 73(1):202-209. DOI: 10.1016/j.jhep.2020.03.039. View

Gaasch W, Zile M . Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry. J Am Coll Cardiol. 2011; 58(17):1733-40. DOI: 10.1016/j.jacc.2011.07.022. View

Petta S, Argano C, Colomba D, Camma C, Di Marco V, Cabibi D . Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. J Hepatol. 2014; 62(4):928-33. DOI: 10.1016/j.jhep.2014.11.030. View

Miyazaki Y, DeFronzo R . Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc Diabetol. 2009; 8:44. PMC: 2729732. DOI: 10.1186/1475-2840-8-44. View

Goh V, Le T, Bryant J, Wong J, Su B, Lee C . Novel Index of Maladaptive Myocardial Remodeling in Hypertension. Circ Cardiovasc Imaging. 2017; 10(9). PMC: 5617557. DOI: 10.1161/CIRCIMAGING.117.006840. View

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

10.

Jung C, Rhee E, Kwon H, Chang Y, Ryu S, Lee W . Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis. Endocrinol Metab (Seoul). 2020; 35(1):165-176. PMC: 7090310. DOI: 10.3803/EnM.2020.35.1.165. View

11.

Andersson A, Kelly M, Imajo K, Nakajima A, Fallowfield J, Hirschfield G . Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis. Clin Gastroenterol Hepatol. 2021; 20(11):2451-2461.e3. DOI: 10.1016/j.cgh.2021.09.041. View

12.

Pischon T, Girman C, Hotamisligil G, Rifai N, Hu F, Rimm E . Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291(14):1730-7. DOI: 10.1001/jama.291.14.1730. View

13.

Rayner J, Banerjee R, Holloway C, Lewis A, Peterzan M, Francis J . The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity. Int J Obes (Lond). 2017; 42(3):441-447. PMC: 5880580. DOI: 10.1038/ijo.2017.239. View

14.

Bodhini D, Mohan V . Mediators of insulin resistance & cardiometabolic risk: Newer insights. Indian J Med Res. 2018; 148(2):127-129. PMC: 6206760. DOI: 10.4103/ijmr.IJMR_969_18. View

15.

Wu Y, Zhang A, Hamilton D, Deng T . Epicardial Fat in the Maintenance of Cardiovascular Health. Methodist Debakey Cardiovasc J. 2017; 13(1):20-24. PMC: 5385790. DOI: 10.14797/mdcj-13-1-20. View

16.

Le T, Tan R, De Deyn M, Goh E, Han Y, Leong B . Cardiovascular magnetic resonance reference ranges for the heart and aorta in Chinese at 3T. J Cardiovasc Magn Reson. 2016; 18:21. PMC: 4830061. DOI: 10.1186/s12968-016-0236-3. View

17.

Waddell T, Bagur A, Cunha D, Thomaides-Brears H, Banerjee R, Cuthbertson D . Greater ectopic fat deposition and liver fibroinflammation and lower skeletal muscle mass in people with type 2 diabetes. Obesity (Silver Spring). 2022; 30(6):1231-1238. PMC: 9321120. DOI: 10.1002/oby.23425. View

18.

Lafontan M, Berlan M . Do regional differences in adipocyte biology provide new pathophysiological insights?. Trends Pharmacol Sci. 2003; 24(6):276-83. DOI: 10.1016/S0165-6147(03)00132-9. View

19.

El Hadi H, Di Vincenzo A, Vettor R, Rossato M . Relationship between Heart Disease and Liver Disease: A Two-Way Street. Cells. 2020; 9(3). PMC: 7140474. DOI: 10.3390/cells9030567. View

20.

Schaapman J, Tushuizen M, Coenraad M, Lamb H . Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease. J Magn Reson Imaging. 2020; 53(6):1623-1631. PMC: 8247423. DOI: 10.1002/jmri.27292. View